Abstract
We hypothesized that longer and more frequent dosing gaps among boys in Botswana taking antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection compared to girls could account for previously seen gender-specific differences in outcomes. We monitored 154 male and 134 female adolescents for 2 years with medication event monitoring systems (MEMS). Median adherence was 95.6 % for males and 95.7 % for females (p = 0.40). There were no significant gender differences in the number of ≥7 day (p = 0.55) and ≥14 day (p = 0.48) dosing gaps. The median maximal gap was 7.7 days for males and 8.0 days for females (p = 0.47). These findings are not consistent with clinically meaningful gender differences in adherence.
Resumen
La hipótesis respecto a brechas de dosificación más largas y frecuentes entre niños en Botswana que reciben tratamiento antirretroviral (TAR) para la infección por virus de la inmunodeficiencia humana (VIH) infección comparada con niñas podría considerar las diferencias específicas de género en los resultados vistos anteriormente. Hicimos un seguimiento a 154 hombres y 134 mujeres adolescentes durante 2 años con medication event monitoring systems (MEMS). La adherencia media fue de 95.6 % para los niños/hombres y 95.7 % para las niñas/mujeres (p = 0.40). No hubo diferencias significativas de género en el número de ≥7 días (p = 0.55) y ≥ 14 días (p = 0.48) brechas de dosificación. La diferencia máxima media fue de 7.7 días para los hombres y 8.0 días para las mujeres (p = 0.47). Estos hallazgos no son consistentes con las diferencias de género clínicamente significativas en la adherencia.
References
Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndrc. 2009;51(1):65–71.
Lowenthal ED, Ellenberg JH, Machine E, Sagdeo A, Boiditswe S, Steenhoff AP, et al. Association between efavirenz-based compared with nevirapine-based antiretroviral regimens and virological failure in HIV-infected children. JAMA. 2013;309(17):1803–9.
Larson RW, Verma S. How children and adolescents spend time across the world: work, play, and developmental opportunities. Psychol Bull. 1999;125(6):701–36.
Mueller E. The value and allocation of time in rural Botswana. J Dev Econ. 1984;15(1–3):329–60.
Bova CA, Fennie KP, Knafl GJ, Dieckhaus KD, Watrous E, Williams AB. Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. AIDS Behav. 2005;9(1):103–10.
Parienti J-J, Das-Douglas M, Massari V, Guzman D, Deeks SG, Verdon R, et al. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One. 2008;3(7):e2783.
Haberer JE, Kiwanuka J, Nansera D, Ragland K, Mellins C, Bangsberg DR. Multiple Measures Reveal Antiretroviral Adherence Successes and Challenges in HIV-Infected Ugandan Children. PLoS One. 2012;7(5):e36737.
Müller AD, Bode S, Myer L, Roux P, von Steinbüchel N. Electronic measurement of adherence to pediatric antiretroviral therapy in South Africa. Pediatr Infect Dis J. 2008;27(3):257–62.
Müller AD, Jaspan HB, Myer L, Lewis Hunter A, Harling G, Bekker L-G, et al. Standard measures are inadequate to monitor pediatric adherence in a resource-limited setting. AIDS Behav. 2011;15(2):422–31.
Sawilowsky S. Misconceptions leading to choosing the t test over the Wilcoxon Mann-Whitney test for shift in location parameter. J Mod Appl Stat Methods [Internet]. 2005;4(2). http://digitalcommons.wayne.edu/jmasm/vol4/iss2/26. Accessed on 1 Nov 2005.
Auld AF, Agolory SG, Shiraishi RW, Wabwire-Mangen F, Kwesigabo G, Mulenga M, et al. Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults—seven African countries, 2004–2013. MMWR Morb Mortal Wkly Rep. 2014;63(47):1097–103.
May M, Sterne JAC, Sabin C, Costagliola D, Justice AC, Thiébaut R, et al. Prognosis of HIV-1-infected patients up to 5 years after initiation of ART: collaborative analysis of prospective studies. AIDS Lond Engl. 2007;21(9):1185–97.
Gross R, Aplenc R, Tenhave T, Foulkes AS, Thakur R, Mosepele M, et al. Slow efavirenz metabolism genotype is common in Botswana. J Acquir Immune Defic Syndr. 2008;49(3):336–7.
Kikuchi K, Poudel KC, Muganda J, Majyambere A, Otsuka K, Sato T, et al. High risk of ART non-adherence and delay of ART initiation among HIV positive double orphans in Kigali, Rwanda. PLoS One. 2012;7(7):e41998.
Acknowledgments
The study team would like to thank the staff at the Botswana Baylor Children’s Clinical Centre of Excellence; Dr. Sean Hennessy for support of the lead author; and Ms. Diana Idarraga Rico for Spanish translation of the abstract. The lead author’s research experiences was funded through a Stolley Award from the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania. This work was funded in part by NIH K23 MH095669 and a PEPFAR Public Health Effectiveness Research Grant (EL). The study team also received support through the International Core of the Penn Center for AIDS Research (P30 AI045008) for the conduct of this study.
Funding
This study was supported in part by the Stolley Award from the Center for Clinical Epidemiology and Biostatistics which funded the lead author’s research experience, by NIH K23 MH095669, by a PEPFAR Public Health Effectiveness Research Grant, and through the International Core of the Penn Center for AIDS Research (P30 AI045008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
All authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed were in accordance with the ethical standards of all institutional and national research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent and assent was obtained from all individual participants included in the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ioannides, K.L., Chapman, J., Marukutira, T. et al. Patterns of HIV Treatment Adherence do not Differ Between Male and Female Adolescents in Botswana. AIDS Behav 21, 410–414 (2017). https://doi.org/10.1007/s10461-016-1530-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-016-1530-7